{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:58:29Z","timestamp":1785895109804,"version":"3.56.0"},"reference-count":40,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS003055-08"],"award-info":[{"award-number":["NS003055-08"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2016.00131","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T05:06:30Z","timestamp":1471237590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment"],"prefix":"10.3389","volume":"7","author":[{"given":"Peter","family":"Kosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Ghazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Ohayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylan","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Lehky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Bielekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,8,15]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ana.21079","article-title":"Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial","volume":"61","author":"Wolinsky","year":"2007","journal-title":"Ann Neurol"},{"issue":"7","key":"B2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1212\/01.wnl.0000335765.55346.fc","article-title":"Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis","volume":"72","author":"Altmann","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"B3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1212\/WNL.0b013e318206ca61","article-title":"Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis","volume":"76","author":"Harrison","year":"2011","journal-title":"Neurology"},{"issue":"19","key":"B4","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1002\/sim.3280","article-title":"Optimizing the design of clinical trials where the outcome is a rate. Can estimating a baseline rate in a run-in period increase efficiency?","volume":"27","author":"Frost","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"B5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"Neuroimage"},{"issue":"3","key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/acn3.293","article-title":"Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis","volume":"3","author":"Komori","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"B7","volume-title":"SAS\/STAT\u00ae9.22 User\u2019s Guide","author":"SAS Institute Inc.","year":"2010"},{"issue":"11","key":"B8","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"10","key":"B9","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.34.10.1368","article-title":"A neurologic rating scale (NRS) for use in multiple sclerosis","volume":"34","author":"Sipe","year":"1984","journal-title":"Neurology"},{"issue":"4","key":"B10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/135245859900500409","article-title":"The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS society clinical outcomes assessment task force","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult Scler"},{"issue":"2","key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2007.06.026","article-title":"Transcranial magnetic stimulation: a primer","volume":"55","author":"Hallett","year":"2007","journal-title":"Neuron"},{"issue":"9","key":"B12","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/nbm.2920","article-title":"Improved Bloch-Siegert based B1 mapping by reducing off-resonance shift","volume":"26","author":"Duan","year":"2013","journal-title":"NMR Biomed"},{"issue":"4","key":"B13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/jmri.21130","article-title":"High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI)","volume":"26","author":"Deoni","year":"2007","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"B14","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.neuroimage.2009.09.005","article-title":"A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions","volume":"49","author":"Shiee","year":"2010","journal-title":"Neuroimage"},{"issue":"5","key":"B15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/mrm.20426","article-title":"RESTORE: robust estimation of tensors by outlier rejection","volume":"53","author":"Chang","year":"2005","journal-title":"Magn Reson Med"},{"issue":"4","key":"B16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.neuroimage.2007.02.056","article-title":"Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T","volume":"36","author":"Landman","year":"2007","journal-title":"Neuroimage"},{"issue":"4","key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v053.i04","article-title":"GA: a package for genetic algorithms in R","volume":"53","author":"Scrucca","year":"2013","journal-title":"J Stat Softw"},{"key":"B18","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2016"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-0318-1","volume-title":"Mixed-Effects Models in S and S-PLUS","author":"Pinheiro","year":"2000"},{"key":"B20","author":"Pinheiro","year":"2014","journal-title":"nlme: Linear and Non-linear Mixed Effects Models. R package Version 3.1-117"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/bjo.2010.193581","article-title":"Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis","volume":"96","author":"Bock","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"B22","volume-title":"Adaptation in Natural and Artificial Systems","author":"Holland","year":"1975"},{"key":"B23","volume-title":"Genetic Algorithms in Search, Optimization, and Machine Learning","author":"Goldberg","year":"1989"},{"key":"B24","volume-title":"Introduction to Genetic Algorithms","author":"Sivanandam","year":"2008"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.c01","article-title":"Beanplot: a boxplot alternative for visual comparison of distributions","volume":"28","author":"Kampstra","year":"2008","journal-title":"J Stat Softw"},{"issue":"2","key":"B26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S1474-4422(14)70264-9","article-title":"Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives","volume":"14","author":"Ontaneda","year":"2015","journal-title":"Lancet Neurol"},{"issue":"7","key":"B27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1474-4422(10)70131-9","article-title":"Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"9","author":"Kapoor","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"B28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1176\/appi.ajp.2015.15060753","article-title":"Finding the elusive psychiatric \u201clesion\u201d with 21st-century neuroanatomy: a note of caution","volume":"173","author":"Weinberger","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"7","key":"B29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/nbm.1543","article-title":"Twenty-five pitfalls in the analysis of diffusion MRI data","volume":"23","author":"Jones","year":"2010","journal-title":"NMR Biomed"},{"issue":"3","key":"B30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mrm.23032","article-title":"In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum","volume":"67","author":"Zhang","year":"2012","journal-title":"Magn Reson Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuroimage.2012.06.081","article-title":"White matter integrity, fiber count, and other fallacies: the do\u2019s and don\u2019ts of diffusion MRI","volume":"73","author":"Jones","year":"2013","journal-title":"Neuroimage"},{"issue":"4","key":"B32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"issue":"22 Suppl 3","key":"B33","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1212\/01.wnl.0000275237.28259.9d","article-title":"Evidence for neuroprotection and remyelination using imaging techniques","volume":"68","author":"Arnold","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"B34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/jnnp.2006.107565","article-title":"Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis","volume":"78","author":"Khaleeli","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"B35","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1001\/archneur.65.11.1454","article-title":"Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis","volume":"65","author":"Khaleeli","year":"2008","journal-title":"Arch Neurol"},{"issue":"7","key":"B36","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jamaneurol.2014.895","article-title":"Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis","volume":"71","author":"Llufriu","year":"2014","journal-title":"JAMA Neurol"},{"key":"B37","first-page":"7723","article-title":"Low-dose (7.5\u2009mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity","volume":"19","author":"Goodkin","year":"1992","journal-title":"Online J Curr Clin Trials"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ana.410370108","article-title":"Low-dose (7.5\u2009mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis","volume":"37","author":"Goodkin","year":"1995","journal-title":"Ann Neurol"},{"issue":"3","key":"B39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.410420318","article-title":"Recommendations from the national multiple sclerosis society clinical outcomes assessment task force","volume":"42","author":"Rudick","year":"1997","journal-title":"Ann Neurol"},{"issue":"13 Pt 2","key":"B40","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1212\/01.wnl.0000288179.86056.e1","article-title":"Responsiveness and predictive value of EDSS and MSFC in primary progressive MS","volume":"70","author":"Kragt","year":"2008","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:43:26Z","timestamp":1498322606000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fneur.2016.00131\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,15]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3389\/fneur.2016.00131","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,15]]}}}